175．Tomoya Tachi, Yoshihiro Noguchi, Hitomi Teramachi, Developing and Verifying the Efficacy of “Educational Program for Promoting Appropriate Self-medication via Pharmacies and Pharmacists”: A Randomized Controlled Trial, Biol. Pharm. Bull.,43, 77-86, 2020.

176．Tomoya Tachi, Yumi Toda, Takayuki Seko, Yoshihiro Noguchi, Hitomi Teramachi, Impact of infection control measures on the related costs and the amount of broad-spectrum antimicrobial agents used in a hospital: a time-series analysis, Int. J. Health Plann. Manage., 35, e133-e141. doi: 10.1002/hpm.2944, 2020.

177．Yoshihiro Noguchi, Hiroki Esaki, Azusa Murayama, Mayuko Sugioka, Aisa Koyama, Tomoya Tachi, Hitomi Teramachi, Association between Dipeptidyl peptidase-4 inhibitor and aspiration pneumonia: disproportionality analysis using the spontaneous reporting system in Japan, Eur. J. Clin. Pharmacol., 76, 299-304, 2020.

178．森美穂，島内あかり，矢島聖子，西尾裕斗，玉木啓文，堺千紘，長内理大，伊野陽子，寺町ひとみ，中村光浩，井口和弘， 機能性表示食品の包装の情報記載状況に関する調査，YAKUGAKU ZASSHI,140, 443-448, 2020.

179．Yoshihiro Noguchi, Tomoya Tachi, Hitomi Teramachi, Comparison of Signal Detection Algorithms Based on Frequency Statistical Model for Drug-Drug Interaction Using Spontaneous Reporting Systems, Pharm. Res., 37, 86. doi: 10.1007/s11095-020-02801-3, 2020.

180．Yoshihiro Noguchi, Tomoya Tachi, Hitomi Teramachi, Subset Analysis for Screening Drug-Drug Interaction Signal Using Pharmacovigilance Database, Pharmaceutics, 12, E762. doi: 10.3390/pharmaceutics12080762, 2020.

181．林剛，舘知也，髙岡みらい，野口義紘，寺町ひとみ，処方提案や疑義照会におけるチームワーク悪化・ストレス発生に影響する信念対立因子の解明─多変量解析とベイジアンネットワーク解析─， YAKUGAKU ZASSHI，140，1151-1164，2020．

182．小長谷奈美，長内理大，小俣江利果，島内あかり，伊野陽子，玉木啓文，山下修司，野口義紘，井口和弘，寺町ひとみ，岐阜薬科大学附属薬局における電話相談内容の解析調査， 医療薬学，46，515-530，2020．

183．Yoshihiro Noguchi, Mirai Takaoka, Tsuyoshi Hayashi, Tomoya Tachi, Hitomi Teramachi, Antiepileptic combination therapy with Stevens-Johnson syndrome and toxic epidermal necrolysis: Analysis of a Japanese pharmacovigilance database, Epilepsia, 61, 1979-1989,2020.

184．伊野陽子，舘知也，山下修司，野口義紘，井口和弘，寺町ひとみ，かかりつけ薬局・薬剤師のための研修会の実施とその評価，日本ファーマシューティカルコミュニケーション学会会誌，18，4-16，2020．

185．Mayuko Sugioka, Tomoya Tachi, Takashi Mizui, Aisa Koyama, Azusa Murayama, Hayato Katsuno, Takuya Matsuyama, Satoshi Aoyama, Tomohiro Osawa, Yoshihiro Noguchi, Masahiro Yasuda, Chitoshi Goto, Hitomi Teramachi, Effects of the number of drugs used on the prevalence of adverse drug reactions in children, Sci. Rep., 10, 21341. doi: org/10.1038/s41598-020-78358-3, 2020.

186．Yoshihiro Noguchi, Keisuke Aoyama, Satoaki Kubo, Tomoya Tachi, Hitomi Teramachi, Improved Detection Criteria for Detecting Drug-Drug Interaction Signals Using the Proportional Reporting Ratio, Pharmaceuticals, 14, 4. doi: 10.3390/ph14010004, 2021.

187．Manabu Toyoshima, Yoshihiro Noguchi, Manami Otsubo, Tomoya Tachi, Hitomi Teramachi, Differences in detected safety signals between benzodiazepines and non-benzodiazepine hypnotics: pharmacovigilance study using a spontaneous reporting system, Int. J. Med. Sci., 18, 1130-1136. doi:10.7150/ijms.51658, 2021.